Asalyxa

0 followers


Asalyxa bio is a novel biotech innate immune system targeting platform looking to regulate immune system response to prevent severe reactions through the power of immunotherapy.

Industries

Headquarters

Employees

Links

Org chart

Marc Appel
Founder & CEO

Marc Appel

Collapse
Lola Eniola-Adefeso
CSO & Founder
Bruce Auerbach
Head, Preclinical Development
Bill Miller
Senior Chemistry Advisor
Ken Olivier
Head, Toxicology
Bruce Weaver
Head, CMC
Garin M.
General Counsel